B-cell lymphoma is a malignant tumor originating from B lymphocytes, and low grade indicates that the tumor cells are relatively less malignant pathologically and have a better prognosis.
There are various ways to classify lymphoma. If the World Health Organization’s classification is used, it can be divided into various types such as precursor lymphoid tumors, mature B-cell lymphoma, mature T/NK-cell lymphoma, and Hodgkin’s lymphoma, etc. B-cell lymphomas are tumors originating from B-cells, including follicular lymphomas and so on.
Low-grade is a kind of pathological examination result, which indicates that the heterogeneity of the tumor specimen is relatively low, and the degree of abnormality of its nuclear schizophrenic image and other indexes is low compared with highly malignant tumors, so the prognosis is better compared with that of high-grade tumors after active treatment. Therapeutic drugs include cyclophosphamide, vincristine, adriamycin, dexamethasone and so on.
Patients with B-cell lymphoma are advised to visit a hospital promptly and receive treatment under the guidance of a physician.